Loading compound...
Small molecule research compound
ENDOXIFEN is a small molecule currently being studied in clinical research. It is being investigated for its potential use in treating bipolar I disorder and various types of breast cancer, including triple-negative breast cancer and breast carcinoma.
Used for
Bipolar I disorderAngiosarcomaTriple-negative breast cancerBreast cancerBreast carcinomaBreast ductal carcinoma in situNeoplasms
Conditions
Bipolar I disorderAngiosarcomaTriple-negative breast cancerBreast cancerBreast carcinomaBreast ductal carcinoma in situNeoplasm
Class
Small moleculeSmall molecule research compound
How to take
ENDOXIFEN is currently in clinical development phases and is not an FDA-approved medication for any indication listed above. Information is based on research data and clinical trial phases (Max Phase 1.0-3.0).
Talk to your doctor
Questions to ask
- ·Is ENDOXIFEN part of any clinical trials I might qualify for?
- ·How does ENDOXIFEN differ from my current cancer or bipolar medications?
Educational summary derived from FDA labeling, AI-assisted. Not medical advice — consult a healthcare professional. Updated 2026-04-26.
